Considerations for Internalizing vs Partnering for Product Development & Manufacturing

Session details:

As drug delivery systems grow more complex, companies must carefully decide which capabilities to build internally and which to access through external partnerships. This panel will examine the strategic, operational, and financial factors that influence this decision, including speed to market, IP considerations, risk management, scalability and access to specialized expertise. Panelists will share practical guidance on structuring successful collaborations and aligning development and manufacturing strategies with long-term business goals.